EUVIMEDEUVIMED entdecken
Crossref

Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform

Lian-Hua Fu, Mengting Yin, Xin Chen, Chen Yang iD, Jing Lin iD, Xiansong Wang, Baoguo Jiang, Peng Huang iD

Nano Letters · 2025

DOI: 10.1021/acs.nanolett.4c05221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Lian-Hua Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engin…. Hauptthemen laut MEDLINE: Osteoporosis, Glucose Oxidase, Catalase, Diabetes Complications. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science and Technology Planning Project of Shenzen Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic osteoporosis (DOP) is a chronic complication of diabetes mellitus (DM) that impairs bone health, and effective management of DOP remains a formidable challenge. In this study, we developed a biocatalytic cascade nanoplatform, GOx@SrCaP-CAT-Tet, offering osteogenic, angiogenic, and anti-inflammatory activities for targeted DOP management. The platform includes glucose oxidase (GOx) and catalase (CAT), encapsulated in strontium-doped calcium phosphate (SrCaP), converting glucose into gluconic acid and hydrogen peroxide (H2O2), alleviating the hyperglycemia and promoting hypoxia-induced vascularization. Both the generated H2O2 and any overabundance of H2O2 in the DOP microenvironment can be scavenged by CAT, thus relieving inflammation. Via a surface modified with tetracycline (Tet) for bone targeting, the release of Sr2+, Ca2+, and PO43- can stimulate osteogenesis and suppress osteoclastogenesis, thereby hastening bone formation and reversing osteoporosis. This nanoplatform shows promise in managing DOP both in vitro and in vivo. Our findings open a new horizon for managing DOP through biocatalytic cascade reactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisGlucose OxidaseCatalaseDiabetes ComplicationsAnimalsMiceOsteogenesisCalcium PhosphatesHydrogen PeroxideHumansBiocatalysisStrontiumTetracyclineRAW 264.7 Cells

Stichwörter der Autor:innen

biocatalytic cascade reactioncatalasediabetic osteoporosisglucose oxidasestrontium-doped calcium phosphate

Substanzen

Glucose OxidaseCatalaseCalcium PhosphatesHydrogen PeroxideStrontiumcalcium phosphateTetracycline

Autor:innen und Institutionen

  • Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenz…
  • Department of Plastic and Reconstructive Surgery, Shanghai Key Laboratory of Tissue Engineering, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
  • Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325000, China.
  • The Third Affiliated Hospital of Xinxiang Medical University, Clinical Medical Center of Tissue Engineering and Regeneration, Xinxiang Medical University, Xinxiang, Henan 453003, China.
  • National Center for Trauma Medicine, Key Laboratory of Trauma and Neural Regeneration, Ministry of Education, Department of Orthopedics and Trauma, Peking University People's Hospital, Beijing 100044, China.
  • Shenzhen University General Hospital, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong 518055, China.

ORCID-Profile: Chen Yang, Jing Lin, Peng Huang

Förderung

  • National Key Research and Development Program of China
  • Science and Technology Planning Project of Shenzen Municipality
  • National Natural Science Foundation of China
  • Shenzhen University
  • Shenzhen Medical Research Fund

Zitieren

APA

Fu, L. H., Yin, M., Chen, X., Yang, C., Lin, J., Wang, X., Jiang, B., & Huang, P. (2025). Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c05221

Vancouver

Fu LH, Yin M, Chen X, Yang C, Lin J, Wang X, et al. Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform. Nano Letters. 2025. doi:10.1021/acs.nanolett.4c05221

BibTeX
@article{Fu2025,
  author = {Fu, Lian-Hua and Yin, Mengting and Chen, Xin and Yang, Chen and Lin, Jing and Wang, Xiansong and Jiang, Baoguo and Huang, Peng},
  title = {Targeted Management of Diabetic Osteoporosis by Biocatalytic Cascade Reaction Nanoplatform},
  journal = {Nano Letters},
  year = {2025},
  doi = {10.1021/acs.nanolett.4c05221}
}
Kostenlos starten →